Skip to main content

Advertisement

Log in

Diagnosing cytomegalovirus in patients with inflammatory bowel disease—by immunohistochemistry or polymerase chain reaction?

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Cytomegalovirus (CMV) reactivation is a common complication in patients with inflammatory bowel diseases (IBD), particularly in those with steroid-resistant ulcerative colitis. It is usually diagnosed by histopathologic and immunohistochemical examination of the colon biopsy. The introduction of quantitative, real-time polymerase chain reaction (qPCR) has been recommended to improve the sensitivity, but there is little consensus on how to use it. We compared the two methods in samples from resected bowel of patients with IBD. Twelve patients with IBD who had undergone bowel resection were analysed for CMV, using qPCR and immunohistochemistry. In all cases, tissue samples from the base and the edge of ulcers and from uninvolved mucosa were obtained. The highest densities of CMV-positive cells were found in samples from the base of ulcers (immunohistochemistry 0–0.47 positive cells/mm2; qPCR 10–3809 viral copies/mg) or the edge of ulcers (immunohistochemistry 0.06–0.32 positive cells/mm2; qPCR 35–1049 viral copies/mg). In samples of uninvolved mucosa, immunohistochemistry was negative, whereas qPCR was either negative or showed very low values (0–3 viral copies/mg). We conclude that both immunohistochemistry and qPCR can be successfully used for diagnosing CMV reactivation in patients with IBD. The base and the edge of ulcers are the optimal sites for endoscopic biopsies. The density of CMV-positive cells was low and their distribution within the colon uneven. It therefore seems that the number of sampled biopsies and/or the number of investigated levels is more important that the choice of diagnostic method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Landolfo S, Gariglio M, Gribaudo G, Lembo D (2003) The human cytomegalovirus. Pharmacol Ther 98:269–297

    Article  CAS  PubMed  Google Scholar 

  2. Crough K, Khanna R (2009) Immunobiology of cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22:76–98

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34:1094–1097

    Article  PubMed  Google Scholar 

  4. You DM, Johnson MD (2012) Cytomegalovirus infection and the gastrointestinal tract. Curr Gastroenterol Rep 14:334–342

    Article  PubMed  Google Scholar 

  5. Kambham N, Vij R, Cartwright CA, Longacre T (2004) Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 28:365–373

    Article  PubMed  Google Scholar 

  6. Kandiel A, Lashner B (2006) Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 101:2857–2865

    Article  CAS  PubMed  Google Scholar 

  7. Domènech E, Vega R, Ojanguren I, Hernández A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E, Gassull MA (2008) Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 14:1373–1379

    Article  PubMed  Google Scholar 

  8. Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip JM, Chambonnière ML, Garraud O, Peyrin-Biroulet L, Pozzetto B (2011) Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 106:2001–2008

    Article  CAS  PubMed  Google Scholar 

  9. Maher MM, Nassar MI (2009) Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci 54:245662

    Article  Google Scholar 

  10. Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L (2010) Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 55:1059–1065

    Article  PubMed  Google Scholar 

  11. Nakase H, Yoshino T, Honzawa Y, Chiba T (2010) Low prevalence of CMV infection in patients with Crohn’s disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci 55:1498–1499

    Article  PubMed  Google Scholar 

  12. Lawlor G, Moss AC (2010) Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis 16:1620–1627

    Article  PubMed  Google Scholar 

  13. Hamlin PJ, Shah MN, Scott N, Wyatt JI, Howdle PD (2004) Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature. Postgrad Med J 80:233–235

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J (2004) The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 10:245–250

    Article  PubMed  Google Scholar 

  15. Pillet S, Pozzetto B, Jarlot C, Paul S, Roblin X (2012) Management of cytomegalovirus infection in inflammatory bowel diseases. Dig Liver Dis 44:541–548

    Article  CAS  PubMed  Google Scholar 

  16. Garrido E, Carrera E, Manzano R, Lopez-Sanroman A (2013) Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol 19:17–25

    Article  PubMed Central  PubMed  Google Scholar 

  17. Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, Sato T, Inoue N, Ogata H, Hibi T (2007) Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 102:331–337

    Article  PubMed  Google Scholar 

  18. Delvincourt M, Lopez A, Pillet S, Bourrier A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X, Peyrin-Biroulet L, Sokol H (2014) The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther 39:712–720

    Article  CAS  PubMed  Google Scholar 

  19. Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, Esteve M, Katsanos K, Lees CW, Macmahon E, Moreels T, Reinisch W, Tilg H, Tremblay L, Veereman-Wauters G, Viget N, Yazdanpanah Y, Eliakim R, Colombel JF, European Crohn’s Colitis Organisation (ECCO) (2014) Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 8:443–468

    Article  CAS  PubMed  Google Scholar 

  20. Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA (2001) Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 96:2137–2142

    Article  CAS  PubMed  Google Scholar 

  21. Maconi G, Colombo E, Zerbi P, Sampietro GM, Fociani P, Bosani M, Cassinotti A, Casini V, Russo A, Ardizzone S, Porta M, Bianchi Porro G (2005) Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 37:418–423

    Article  CAS  PubMed  Google Scholar 

  22. Al-Zafiri R, Gologan A, Galiatsatos P, Szilagyi A (2012) Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol (N Y) 8:230–239

    Google Scholar 

  23. Muir SW, Murray J, Farquharson MA, Wheatley DJ, McPhaden AR (1998) Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR. J Clin Pathol 51:807–811

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, Hasegawa S, Sakai Y, Chiba T (2007) Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 13:1516–1521

    Article  PubMed  Google Scholar 

  25. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R, European Society of Pathology (ESP); European Crohn’s and Colitis Organisation (ECCO) (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7:827–851

    Article  CAS  PubMed  Google Scholar 

  26. Boeckh M (2011) Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematol Am Soc Hematol Educ Program 2011:305–309

    Article  Google Scholar 

  27. Ljungman P, de la Camara R, Cordonnier C, Einsele H, Engelhard D, Reusser P, Styczynski J, Ward K (2008) Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 42:227–240

    Article  CAS  PubMed  Google Scholar 

  28. Ganzenmueller T, Henke-Gendo C, Schlué J, Wedemeyer J, Huebner S, Heim A (2009) Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease. J Clin Virol 46:254–258

    Article  CAS  PubMed  Google Scholar 

  29. Lemonovich TL, Watkins RR (2012) Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients. Curr Infect Dis Rep 14:33–40

    Article  PubMed  Google Scholar 

  30. Mills AM, Guo FP, Copland AP, Pai RK, Pinsky BA (2013) A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissue. Am J Surg Pathol 37:995–1000

    Article  PubMed  Google Scholar 

  31. McCoy MH, Post K, Sen JD, Chang HY, Zhao Z, Fan R, Chen S, Leland D, Cheng L, Lin J (2014) qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies. Hum Pathol 45:48–53

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nina Zidar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zidar, N., Ferkolj, I., Tepeš, K. et al. Diagnosing cytomegalovirus in patients with inflammatory bowel disease—by immunohistochemistry or polymerase chain reaction?. Virchows Arch 466, 533–539 (2015). https://doi.org/10.1007/s00428-015-1741-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-015-1741-8

Keywords

Navigation